What Is It Like to Get Cancer When You're Young? Hundreds of New York Times readers shared their experiences with early-onset cancers. Here are seven of their stories.

Under 40 and Diagnosed with Cancer www.nytimes.com/interactive/...

Major conference catches illicit AI use — and rejects hundreds of papers The papers’ watermarks allowed organizers to detect use of large language models in peer review.

Major conference catches illicit AI use — and rejects hundreds of papers www.nature.com/articles/d41...

Thanks to @ethicsdoctorp.bsky.social and @acochran12733.bsky.social for a wonderful Editorial Board meeting at @ascocancer.bsky.social headquarters !

AI can spark creativity — if we ask it how, not what, to think Studies aiming to maximize human creativity demonstrate that people work best when buoyed up by others who show them new ways to innovate.

AI can spark creativity — if we ask it how, not what, to think www.nature.com/articles/d41...

Editorial Advisory Board

ascoai.org/editorial-ad... honored to join this distinguished panel !

x.com/jama_current...

Use of Ablative Radiotherapy in the Setting of Oligometastatic Disease | JCO Oncology Practice ascopubs.org/doi/10.1200/...

‘An AlphaFold 4’ – scientists marvel at DeepMind drug spin-off’s exclusive new AI Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left guessing how to achieve similar results.

‘An AlphaFold 4’ – scientists marvel at DeepMind drug spin-off’s exclusive new AI www.nature.com/articles/d41...

AI is threatening science jobs. Which ones are most at risk? Data-analysis and modelling positions are already becoming obsolete, but hands-on experimentalists can breathe easy for now.

AI is threatening science jobs. Which ones are most at risk? www.nature.com/articles/d41...

Are obesity drugs causing a severe complication? What the science says The United Kingdom and Brazil have issued warnings about a possible link between GLP-1 weight-loss drugs and pancreatic inflammation, but the connection is murky.

Are obesity drugs causing a severe complication? What the science says www.nature.com/articles/d41...

Exercise rewires the brain — boosting the body’s endurance The more mice exercise, the more connections form between some neurons in their brains, study finds.

Exercise rewires the brain — boosting the body’s endurance www.nature.com/articles/d41...

Congratulations to Dr. Betty Hamilton and the entire Cleveland Clinic team at the Transplantation & Cellular Therapy (Tandem) Meetings in Seattle! @ClevelandClinic and @ASTCT with excellence on the national stage.
Well done, Dr. Hamilton Marcelo Pasquini Claudio Brunstein and team! 👏🎉

The surprisingly big health benefits of just a little exercise ‘Exercise snacks’ and other forms of everyday movement can greatly reduce the risk of heart disease and death.

The surprisingly big health benefits of just a little exercise www.nature.com/articles/d41...

Cancer care and research is changing! I talk about 3 transformative changes in cancer care and research @clevelandclinic.bsky.social

So proud of our clinical researchers at @clevelandclinic.bsky.social at @nrgonc.bsky.social reception !

Three tips for scientific writing: a guide for graduate students Do you struggle with the blank page? These strategies could help.

Three tips for scientific writing: a guide for graduate students www.nature.com/articles/d41...

A Message from the Chairs of NRG Oncology’s Research Strategy Committee - 2025: The Year in Review ➡️https://ow.ly/U7mT50XVJX7
Jame Abraham, MD, FACP

acsjournals.onlinelibrary.wiley.com/doi/10.3322/...

www.nrgoncology.org/meetings/202... looking forward to the @nrgonc.bsky.social scientific session to present DESTINY 05 Data

Who should be getting a genetic testing ? @clevelandclinic.bsky.social

The best foods for healthy ageing ― and the worst Study of more than 100,000 people supports your parents’ advice: eat your veggies.

The best foods for healthy ageing ― and the worst www.nature.com/articles/d41...

Science in 2050: the future breakthroughs that will shape our world — and beyond Nuclear fusion. People on Mars. Artificial general intelligence. These are just some of the advances that could come by the mid-century mark.

Science in 2050: the future breakthroughs that will shape our world — and beyond www.nature.com/articles/d41...

Nine books to help shape your science career in 2026 If you’ve hatched a New Year plan to move abroad, improve your presentations or chase happiness as a 20-something researcher, you’ll find advice aplenty in these books.

Nine books to help shape your science career in 2026 www.nature.com/articles/d41...

Science in 2026: the events to watch for in the coming year The rise of AI scientists, missions to explore the moons of Earth and Mars and a massive ocean-floor drill are among the developments set to shape research in 2026.

Science in 2026: the events to watch for in the coming year www.nature.com/articles/d41...

Wish you Happy Holidays and Merry Christmas! Peace and love 💕

DESTINY 05 trial - in high risk her - 2 positive #breastcancer - 53% reduction in invasive disease free survival with TDXd - @NSABPFoundation @myesmo.bsky.social @oncoalert.bsky.social ! Honored to be part of the study ! @clevelandclinic.bsky.social

It was a beautiful and blessed weekend for the Abraham family—our son Abel married Kathryn!

Artificial Intelligence in Oncology Jame Abraham, MD, Chair of the Department of Hematology & Medical Oncology at Cleveland Clinic Cancer Institute, joins the Cancer Advances Podcast to discuss how artificial intelligence (AI) is transf...

From improving efficiency to advancing research, AI is transforming oncology. I joined @Shepard Dale on the @CleClinicMD Cancer Advances podcast to discuss what this means for patients and providers. #CleClinicCancer cle.clinic/41OwRO8

David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87

David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87 www.nytimes.com/2025/09/07/s...

BioNTech's HER2 ADC beats Roche's Kadcyla in phase 3 breast cancer trial BioNTech’s HER2 antibody-drug conjugate has beaten< | BioNTech’s HER2 antibody-drug conjugate has beaten Roche’s Kadcyla in a phase 3 breast cancer trial, positioning the company’s partner Duality Bio...

www.fiercebiotech.com/biotech/bion...